Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Frontiers in Cancer Immunotherapy 2021

WEBINAR

Only

Frontiers in Cancer Immunotherapy 2021

Wednesday, May 12, 2021, 10:30 AM - Friday, May 14, 2021, 5:00 PM EDT

Virtual Symposium

Presented By

Cancer Discussion Group

The New York Academy of Sciences

 

In the decade since the approval of the first checkpoint inhibitor, immunotherapy has shifted the paradigm for cancer treatment, delivering effective and durable responses for numerous patients. During that time, combination therapies, adoptive cell therapies, and cancer vaccines have further expanded the impact of immunotherapy.  Nonetheless, challenges remain in understanding why some tumor types are refractive to immunotherapy and how to better predict patient responses to treatment.  This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.

Registration for the event will open soon. Please check back shortly for more information, or follow us on social media for updates!


Keynote Speaker

Irving Weissman, PhD
Irving Weissman, PhD

Stanford University

Speakers

Kristen M. Hege, MD

Bristol Myers Squibb

Katherine Hsu, MD, PhD

Memorial Sloan Kettering Cancer Center

Paolo Ascierto, MD

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli

Eric Smith, MD, PhD

Dana Farber Cancer Institute

Bob Uger, PhD

Trillium Therapeutics

George Coukos, MD, PhD

University of Lausanne

Juliet Barker, MBBS

Memorial Sloan Kettering Cancer Center

Scientific Organizing Committee

Chris Boshoff, MD, PhD
Chris Boshoff, MD, PhD

Pfizer

Renier Brentjens, MD, PhD
Renier Brentjens, MD, PhD

Memorial Sloan Kettering Cancer Center

Padmanee Sharma, MD, PhD
Padmanee Sharma, MD, PhD

MD Anderson Cancer Center

George Zavoico, PhD
George Zavoico, PhD

Cue Biopharma

Sara Donnelly, PhD
Sara Donnelly, PhD

The New York Academy of Sciences

Sonya Dougal, PhD
Sonya Dougal, PhD

The New York Academy of Sciences